Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod in Acute Ischemic Stroke (REPAIR FAST)
NCT04718064Unknown
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Feb 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in ischemic stroke comparing Fingolimod + Standard Therapy with Placebo + Standard Therapy (2 arms). Primary endpoint: modified Rankin Scale at 90 days. Status: unknown.
02
Drugs
fingolimod
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04718064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04718064.